K Matsueda
Overview
Explore the profile of K Matsueda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsueda K, Manabe N, Toshikuni N, Sato Y, Watanabe T, Yamamoto H, et al.
Dis Esophagus
. 2017 May;
30(6):1-6.
PMID: 28475744
Gastroesophageal reflux disease-related diseases, such as Barrett's esophagus and adenocarcinoma of the esophagogastric junction (AEGJ), are believed to occur less frequently in Asia than in Western countries. However, the number...
2.
Fukudo S, Matsueda K, Haruma K, Ida M, Hayase H, Akiho H, et al.
Neurogastroenterol Motil
. 2017 Feb;
29(6).
PMID: 28205278
Background: Previous studies showed that 5 μg of ramosetron, a serotonin (5-hydroxytryptamine: 5-HT)-3 receptor antagonist, is only effective in male patients with irritable bowel syndrome (IBS) with diarrhea (IBS-D). We...
3.
Ono Y, Matsueda K, Koga R, Takahashi Y, Arita J, Takahashi M, et al.
Br J Surg
. 2014 Dec;
102(3):219-28.
PMID: 25524295
Background: Splenic vein ligation may result in sinistral (left-sided) portal hypertension and gastrointestinal haemorrhage. The aim of this study was to analyse the pathogenesis of sinistral portal hypertension following splenic...
4.
Hosoda S, Shimoyama T, Takahashi T, Bamba T, Kitano A, Matsueda K, et al.
Asia Pac J Clin Nutr
. 2013 Dec;
2(2):63-70.
PMID: 24352101
We examined a nutritional approach to the therapy of Crohn's disease with an enteral formula ('Enterued', Terumo Corporation, Tokyo, Japan) which contains low molecular weight peptides as a protein source....
5.
Matsueda K, Hongo M, Ushijima S, Akiho H
Digestion
. 2011 Sep;
84(4):261-8.
PMID: 21934307
Background: This long-term 48-week study of acotiamide was carried out to investigate the efficacy, safety and administration pattern in patients with functional dyspepsia (FD). Methods: This was a multicenter, open-label,...
6.
Yukisawa S, Fujiwara Y, Yamamoto Y, Ueno T, Matsueda K, Kohno A, et al.
Br J Radiol
. 2010 Mar;
83(994):850-3.
PMID: 20223904
The purpose of the current study was to evaluate the incidence and course of upper-extremity deep vein thrombosis (UEDVT) related to an implanted central venous port (CV-port) system in cancer...
7.
Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H
Neurogastroenterol Motil
. 2010 Jan;
22(6):618-e173.
PMID: 20059698
Background: Acotiamide is a selective acetylcholinesterase inhibitor and enhances the actions of cholinergic neurons localized in the stomach. Methods: The present two studies were conducted to examine the optimal dosage...
8.
Uchida M, Mogami O, Matsueda K
Inflammopharmacology
. 2009 Oct;
15(3):105-8.
PMID: 19847949
After the screening of microorganism culture, the culture of Propionibacterium freudenreichii ET-3 in the milk whey (milk whey culture) was found to stimulate the growth of our own Bifidobacteria in...
9.
Matsueda K, Harasawa S, Hongo M, Hiwatashi N, Sasaki D
Digestion
. 2008 Aug;
77(3-4):225-35.
PMID: 18667823
Background: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Serotonin type 3 (5-HT3) receptor antagonist alosetron hydrochloride is indicated for women with chronic, severe diarrhea-predominant IBS who have not...
10.
Akiyoshi T, Oya M, Fujimoto Y, Kuroyanagi H, Ueno M, Yamaguchi T, et al.
Colorectal Dis
. 2008 Jul;
11(5):464-9.
PMID: 18637927
Objective: Preoperative use of emission tomography with(18)F-fluorodeoxyglucose (FDG-PET) in patients with primary colorectal cancer remains controversial. This study evaluated the additional value of FDG-PET in comparison with routine multidetector row...